Tweetovi

Blokirali ste korisnika/cu @SamHamMW

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @SamHamMW

  1. 1. velj

    detailed review T/Cel Nov 18 CSR tmplt: Dec 19 T/Cel update template + 'Summary Changes' deck: . T/Cel claim 'alignment with CORE'. T/Cel did not contact us; we have not reviewed Dec 19 template. Sam & Art

    Poništi
  2. 26. sij

    Just propagated via the email list - and coming soon with commentary on the EMWA NewsBlast, RPD SIG page and CORE Reference News Summary page

    Poništi
  3. proslijedio/la je Tweet
    24. sij

    The EMWA Regulatory Public Disclosure Special Interest Group (RPD SIG) page on the EMWA website has been updated.

    Poništi
  4. 12. sij

    the Data Economy refers to the mass of data out there - available in this case to clinical research professionals. Pls contact me if you’d like to contribute

    Poništi
  5. 25. lis 2019.

    Proud to have this RPD article IN MEW - thank you Viv

    Poništi
  6. 4. ruj 2019.

    Section 3 ‘Clinical trials of IMPs’: detailed info relevant for CT professionals. See my LinkedIn page for a summary:

    Poništi
  7. proslijedio/la je Tweet
    30. kol 2019.

    To help you plan for the EMWA Autumn conference (7-9 Nov 2019, Malmö, Sweden), a programme preview is now on the website. Please note that this preview is for information purposes only, and is subject to change.

    Poništi
  8. proslijedio/la je Tweet

    Timely and transparent reporting of results helps to reduce waste in research funding. Read about our collaboration with analysing the effects of professional support on clinical trial reporting here:

    Poništi
  9. 6. kol 2019.

    paper Critical Review of the TransCelerate Template for CSRs and Publication of Version 2 of the (Clarity and Openness in Reporting: E3-based) Terminology Table. RIPR 2019.

    Poništi
  10. proslijedio/la je Tweet
    Poništi
  11. 1. srp 2019.

    FDA concludes clinical data summary pilot; seeks feedback on this and new integrated template to support transparency. Public comment open until 26 Aug 19:

    Poništi
  12. proslijedio/la je Tweet
    5. lip 2019.

    Guidance on Conference Abstracts and Presentations published today in . Congratulations to Cate Foster, , , Mina Patel, our own Steve Banner, , Antonia Panayi, Rianne Stacey and Working Group!

    Poništi
  13. proslijedio/la je Tweet
    19. svi 2019.
    Poništi
  14. proslijedio/la je Tweet
    11. svi 2019.

    The best part about EMWA conferences...the lovely people attending it. The unavoidably sad part about EMWA conferences...not having enough time to talk to all of them. Thank you and all delegates for a fabulous . Auf wiedersehen.

    Poništi
  15. 10. svi 2019.

    Enjoying Kathy Thomas’s talk on Data Disclosure and ICMJE requirements. This preceded the Regulatory ESS session which starts at 13.30. Excellent programme is planned.

    Poništi
  16. proslijedio/la je Tweet
    9. svi 2019.

    thanks to those attending the RPD SIG lunchtime update. Good discussions. If you've ideas for articles, or info on RPD get in touch

    Poništi
  17. 4. svi 2019.
    Poništi
  18. 25. tra 2019.

    Regulatory Public Disclosure Special Interest Group (RPD SIG) meets Thu 9 May 19, 1 - 1.30 pm @ EMWA Conference, Vienna - FREE lunchtime session. You are warmly invited to discuss RPD matters and share info.

    Poništi
  19. proslijedio/la je Tweet

    The latest issue of MEW on Careers in Medical Writing is now available online. All articles are open access and are a great source of inspiration for aspiring medical writers. Such a wonderful issue! :)

    Poništi
  20. 22. ožu 2019.

    Health Canada final (12 Mar 19) guidance on Public release of clinical information: Search for publicly posted drug & device information at:

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·